Close
Digital Health & Ai Innovation summit 2026
APE 2026

News

Vizient Inc to Participate in Antibiotic Resistance Panel at 2017 SOA Health Meeting

With the Centers for Disease Control and Prevention reporting at least two million people are infected with multi-drug resistant organisms annually, resulting in 23,000 deaths,...

Allscripts and GoodRx to empower providers in addressing prescription affordability

Allscripts and GoodRx have partnered to deliver a new solution that assists providers and patients in finding the best prescription price options and ultimately helps...

Cyteir Therapeutics Announces Study Showing RAD51 Modulators Protect Diabetic Mice from T1 Diabetes

Cyteir Therapeutics, Inc., a leader in the development of novel therapeutics based on the biology of DNA repair and synthetic lethality announced the publication of pre-clinical...

Community Health Systems Announces Definitive Agreement to Divest Five Pennsylvania Hospitals

Community Health Systems, Inc announced that subsidiaries of the Company have signed a definitive agreement to sell five Pennsylvania hospitals and their associated assets to subsidiaries of...

Sunovion Receives CRL from FDA for SUN-101e Flow New Drug Application for COPD

Sunovion Pharmaceuticals Inc announced that the U.S. FDA issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for SUN-101/eFlow® (glycopyrrolate) for the...

MolecuLight signs exclusive distribution agreement with global wound care leader Smith & Nephew

MolecuLight is pleased to announce the execution of an exclusive global distribution agreement with Smith & Nephew to distribute the MolecuLight i:XTM Imaging Device product...

EnteroMedics Announces First vBloc Neurometabolic Therapy Implant at McGuire Veterans

EnteroMedics Inc , the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, announced that the McGuire Veterans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »